The US healthcare system has been facing great uncertainty, with ongoing challenges to the sustainability of the Affordable Care Act and converging industry pressures on pharmaceutical drug pricing. At Prescient Healthcare Group, our healthcare experts are closely monitoring developments in managed care and health policy, and have observed three key trends influencing the US market access landscape in 2018.
Prescient assessed opportunities across patient segments to guide our client’s go-to-market strategies.
Prescient developed a five-year forecast of potential cellular therapy patients to guide our client’s treatment center qualification strategy.
Prescient conducted a situational analysis of the immunology market to identify high-impact trends and evolving HCP prescribing behaviors to inform and update our client’s brand strategy.
Prescient helped accelerate, assure and simplify the client’s annual medical affairs strategic planning across its solid tumor franchise.
Prescient conducted an in-depth analysis of competitor global medical affairs teams to understand best practices in the industry.
Prescient developed a BD assessment framework to identify attractive candidates in an oncology indication with a high unmet need.
San Francisco
+1 415 230 8460New York
+1 973 347 7750Boston
+1 857 341 0341London
+44 20 8832 7900New Delhi
+91 11 7127 91701Beijing
+86 10 6562 9095
